Skip to main content

Advertisement

Log in

IgG4-related disease in pediatric patients: a single-center experience

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objective

Immunoglobulin G4-related disease (IgG4-RD) is a systemic, immune-mediated, and fibroinflammatory disease that can affect almost any organ system. We aimed to present our single-center experience of pediatric patients with IgG4-RD, a rare disease in children.

Methods

Pediatric patients diagnosed with IgG4-RD at the Hacettepe University between June 2014 and September 2020 were evaluated retrospectively. Patients with definite, probable, or possible diagnosis of IgG4-RD were included.

Results

A total of eight patients with a median age of 13.4 (IQR 9.5–15.0) years were included in the study. Clinical presentations were IgG4-related ophthalmic disease in six patients, IgG4-related lymphadenopathy in one patient, and IgG4-related sialadenitis and lymphadenopathy of several lymph nodes accompanied by pancreatitis, ulcerative colitis, and pulmonary manifestations in one patient. Elevated serum IgG4 was detected in three of eight patients (37.5%). The main histopathological feature was fibrosis and lymphoplasmacytic infiltrates. Corticosteroids were used as first-line treatment in almost all patients with or without steroid-sparing agents. Azathioprine, methotrexate and rituximab were used as steroid-sparing agents. Relapse occurred in two of seven patients. Radiotherapy was used as the last resort in one patient with severe orbital disease.

Conclusion

IgG4 RD mainly presents with orbital manifestations in pediatric population but has wide phenotypic clinical variability. Although rare, early recognition and treatment are essential for a better outcome in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vasaitis L (2016) IgG4-related disease: a relatively new concept for clinicians. Eur J Intern Med 27:1–9

    Article  CAS  Google Scholar 

  2. Lang D, Zwerina J, Pieringer H (2016) IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag 12:189

    Article  CAS  Google Scholar 

  3. Uchida K, Masamune A, Shimosegawa T, Okazaki K (2012) Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol. 2012:358371

    PubMed  PubMed Central  Google Scholar 

  4. Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551

    Article  CAS  Google Scholar 

  5. Al-Khalili OM, Erickson AR (2018) IgG-4 related disease: an introduction. Mo Med 115:253

    PubMed  PubMed Central  Google Scholar 

  6. Brito-Zerón P, Kostov B, Bosch X, Acar-Denizli N, Ramos-Casals M, Stone JH (2016) Therapeutic approach to IgG4-related disease: a systematic review. Medicine 95:4002

    Article  Google Scholar 

  7. Karadağ Ö, Erden A, Ayhan EA, Bolek EÇ, Kalyoncu U, Armağan B et al (2017) The clinical features and outcomes of Turkish patients with IgG4-related disease: a single-center experience. Turk J Med Sci 47:1307–1314

    Article  Google Scholar 

  8. Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, van Hagen M et al (2016) IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol 14:18

    Article  Google Scholar 

  9. Khosroshahi A, Stone JH (2011) A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 23:57–66

    Article  CAS  Google Scholar 

  10. Zen Y, Nakanuma Y (2010) IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 34:1812–1819

    Article  Google Scholar 

  11. Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet 385:1460–1471

    Article  CAS  Google Scholar 

  12. Wallace ZS, Perugino C, Matza M, Deshpande V, Sharma A, Stone JH (2019) Immunoglobulin G4–related Disease. Clin Chest Med 40:583–597

    Article  Google Scholar 

  13. Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E et al (2017) Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series. Medicine. https://doi.org/10.1097/MD.0000000000006205

    Article  PubMed  PubMed Central  Google Scholar 

  14. Mannion M, Cron RQ (2011) Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol 9:1

    Article  Google Scholar 

  15. Andrew N, Kearney D, Selva D (2013) IgG4-related orbital disease: a meta-analysis and review. Acta Ophthalmol 91:694–700

    Article  CAS  Google Scholar 

  16. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22:21–30

    Article  CAS  Google Scholar 

  17. Goto H, Takahira M, Azumi A (2015) Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol 59:1–7

    Article  CAS  Google Scholar 

  18. Martin-Nares E, Díaz-Prieto T, Faugier-Fuentes E, Aparicio Vera L, Hernandez-Molina G (2021) Juvenile-Onset IgG4-Related Disease: A Systematic Review [abstract]. Arthritis Rheumatol. 2019;71 (suppl 10). https://acrabstracts.org/abstract/juvenile-onset-igg4-related-disease-a-systematic-review/. Accessed April 27, 2021

  19. Smerla RG, Rontogianni D, Fragoulis GE (2018) Ocular manifestations of IgG4-related disease in children. More common than anticipated? Review of the literature and case report. Clin Rheumatol. 37:1721–1727

    Article  Google Scholar 

  20. Tille L, Schnabel A, Laass MW, Hahn G, Taut H, Leszczynska A et al (2020) Orbital inflammation and colitis in pediatric IgG4-related disease: A case report and review of the literature. Eur J Rheumatol 7:S21

    Article  Google Scholar 

  21. Akkelle BŞ, Tutar E, Ergelen R, Çelikel ÇA, Ertem D (2020) IgG4 related disease in a seven year old girl with multiple organ involvement: A rare presentation. Turk Pediatri Ars 55:191

    PubMed  PubMed Central  Google Scholar 

  22. Abraham M, Khosroshahi A (2017) Diagnostic and treatment workup for IgG4-related disease. Expert Rev Clin Immunol 13(9):867–875

    Article  CAS  Google Scholar 

  23. Zen Y (2020) Pathological characteristics and diagnosis of IgG4-related disease. Presse Méd. 49:104014

    Article  Google Scholar 

  24. Brito-Zerón P, Ramos-Casals M, Bosch X, Stone JH (2014) The clinical spectrum of IgG4-related disease. Autoimmun Rev 13:1203–1210

    Article  Google Scholar 

  25. Wallace ZS, Deshpande V, Stone JH (2014) Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum 43(6):806–817

    Article  CAS  Google Scholar 

  26. Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H et al (2015) Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 74:190–195

    Article  CAS  Google Scholar 

  27. Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S et al (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheum 67:2466–2475

    Article  CAS  Google Scholar 

  28. Pieringer H, Parzer I, Wöhrer A, Reis P, Oppl B, Zwerina J (2014) IgG4-related disease: an orphan disease with many faces. Orphanet J Rare Dis 9:1–14

    Article  Google Scholar 

  29. Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74:14–18

    Article  CAS  Google Scholar 

  30. Tabata T, Kamisawa T, Takuma K, Anjiki H, Egawa N, Kurata M et al (2009) Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin Chim Acta 408:25–28

    Article  CAS  Google Scholar 

  31. Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A et al (2009) Standard steroid treatment for autoimmune pancreatitis. Gut 58:1504–1507

    Article  CAS  Google Scholar 

  32. Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T (2010) IgG4-related disease: Historical overview and pathology of hematological disorders. Pathol Int 60:247–258

    Article  CAS  Google Scholar 

  33. Deshpande V, Zen Y, Chan JK, Eunhee EY, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192

    Article  Google Scholar 

  34. Kubota T, Moritani S (2012) Orbital IgG4-related disease: clinical features and diagnosis. ISRN Rheumatol. https://doi.org/10.5402/2012/412896

    Article  PubMed  PubMed Central  Google Scholar 

  35. Sato Y, Ohshima Ki, Ichimura K, Sato M, Yamadori I, Tanaka T, et al (2008) Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465–470

  36. Lin Y-H, Yen S-H, Tsai C-C, Kao S-C, Lee F-L (2015) Adjunctive orbital radiotherapy for ocular adnexal IgG4-related disease: preliminary experience in patients refractory or intolerant to corticosteroid therapy. Ocul Immunol Inflamm 23:162–167

    Article  CAS  Google Scholar 

  37. Detiger SE, Karim AF, Verdijk RM, van Hagen PM, van Laar JA, Paridaens D (2019) The treatment outcomes in IgG4-related orbital disease: a systematic review of the literature. Acta Ophthal 97:451–459

    Article  CAS  Google Scholar 

Download references

Funding

No external funding for this manuscript. The authors have indicated they have no financial relationships relevant to this article to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yelda Bilginer.

Ethics declarations

Conflict of Interest

The authors have indicated that they do not have any financial and non-financial potential conflicts of interest to disclose.

Ethics approval

This study has been approved by the Hacettepe University Ethics Commission (GO 20/1172).

Informed consent

Written informed consent was obtained from the presented patients and their parents.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaya Akca, Ü., Atalay, E., Kasap Cüceoğlu, M. et al. IgG4-related disease in pediatric patients: a single-center experience. Rheumatol Int 42, 1177–1185 (2022). https://doi.org/10.1007/s00296-021-04885-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-04885-5

Keywords

Navigation